Nachrichten zur Merck KGaA Aktie

Merck & Co on Thursday reported a loss for the first quarter as an acquisition-related charge offset a 5% increase…

Belén Garijo entscheidet schneller als andere und fördert ungewöhnliche Karrieren. Mit 65 Jahren scheidet sie bei Merck aus und wird…

Merck tops Q1 estimates as Keytruda drives growth and lifts 2026 EPS outlook despite acquisition charge. Sales view tightened.…

Image source: The Motley Fool.DateWednesday, April 29, 2026, 4:30 p.m. ETCall participantsChief Executive Officer — Sundar PichaiSenior Vice President &…

Frankfurt (www.aktiencheck.de) - Merck-Aktienanalyse von XTB:Jeremy Krings, Junior Marktanalyst bei XTB, nimmt die Aktie der Merck KGaA (ISIN: DE0006599905, WKN:…

Image source: The Motley Fool.DATETuesday, April 28, 2026 at 4:30 p.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — John WrenExecutive…

Bad Marienberg (www.aktiencheck.de) - DAX Analyse: Merck, Commerzbank und RWE glänzen – warum Qiagen,Bayer und Öl-Angst den DAX unter 24.100…

By John Vandermosten, CFANASDAQ: ACHVAchieve Life Sciences, Inc. (NASDAQ: ACHV) generated significant news flow in April, announcing the arrival of…

Merck (MRK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

Guggenheim reiterates Buy on Merck stock ahead of earnings…

…

Merck heads into Q1 with strong Keytruda demand but rising pressure from generics, vaccines slump, and deal costs persist. Can…

In the latest trading session, Merck (MRK) closed at $111.9, marking a -2.37% move from the previous day.…

Merck KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung ^ EQS Stimmrechtsmitteilung:…

Merck KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung^EQS Stimmrechtsmitteilung: Merck KGaAMerck KGaA: Veröffentlichung…

FDA grants priority review to Mercks sBLAs for Keytruda & Keytruda SC in combination with Pfizers Padcev in cisplatin-eligible MIBC…

Merck stock up 11% YTD as Keytruda growth, pipeline gains and M&A lift outlook, but patent risks, Gardasil slump and…

In the closing of the recent trading day, Merck (MRK) stood at $117.1, denoting a -1.65% move from the preceding…

UBS reiterates Merck stock rating on pipeline strength…

Both are great stocks to buy in the current environment, but which one is the better bet?…

NEW YORK (dpa-AFX Broker) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Merck KGaA …

NEW YORK (dpa-AFX Broker) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Merck KGaA von 153 auf 147…

Frankfurt (www.aktiencheck.de) - Merck-Aktienanalyse von XTB:Die Experten von XTB nehmen die Aktie der Merck KGaA (ISIN: DE0006599905, WKN: 659990, Ticker-Symbol:…

The FDA grants priority review to Merck and Daiichis BLA for ifinatamab deruxtecan to treat extensive-stage small cell lung cancer.…

In the latest trading session, Merck (MRK) closed at $120.15, marking a -1.05% move from the previous day.…

Wien (www.aktiencheck.de) - Merck-Aktienanalyse der Raiffeisen Bank International AG:Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), rät in einer…

Daniel Goldstein hat festgestellt, dass das Krebsmedikament Keytruda in zu hohen Dosen verabreicht wird. Der Hersteller verdient damit Milliarden –…

The pharmaceutical giant is a standout performer within the health-care sector, and the stock could be poised for a big…

Though both dominate oncology, a stronger growth outlook and clearer targets may give AstraZeneca an edge over Merck.…

Image source: The Motley Fool.DateTuesday, Nov. 4, 2025 at 8:30 a.m. ETCall participantsChief Executive Officer — Kristin PeckChief Financial Officer…

Image source: The Motley Fool.DATETuesday, May 6, 2025 at 8:30 a.m. ETCALL PARTICIPANTSChief Executive Officer — Kristin PeckChief Financial Officer…

The latest trading day saw Merck (MRK) settling at $119.28, representing a -1.3% change from its previous close.…

…

…

Merck (MRK) concluded the recent trading session at $120.29, signifying a +1.85% move from its prior days close.…

Merck (MRK) reached $118.1 at the closing of the latest trading day, reflecting a -1.28% change compared to its last…

…

MRK stock has surged over 50% in six months, but looming patent risks and weak vaccine sales raise questions on…

Frankfurt (www.aktiencheck.de) - Merck-Aktienanalyse von XTB:Die Experten von XTB nehmen die Aktie der Merck KGaA (ISIN: DE0006599905, WKN: 659990, Ticker-Symbol:…

Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock…

Bad Marienberg (www.aktiencheck.de) - Dow Jones Analyse: Friedenshoffnung treibt Dow Jones höher. Sherwin-Williams, Merck Amazon führen den Befreiungsschlag anDow…

…

Merck übernimmt das HBM-Portfoliounternehmen Terns Pharmaceuticals für USD 6.7 Milliarden^HBM Healthcare Investments AG / Schlagwort(e): Ankauf/PartnerschaftMerck übernimmt das HBM-Portfoliounternehmen Terns…

Der US-Pharmakonzern will Terns für 6,7 Milliarden Dollar übernehmen. Damit sichert sich Merck & Co das Blutkrebsmedikament des Biotechunternehmens.…

Merck is trying to bulk up its portfolio ahead of its best-selling cancer drug Keytruda losing patent protection in 2028.…

EQS-DD: Merck KGaA: Freifrau Helene Röder von Diersburg, Kauf ^ Meldung und öffentliche Bekanntgabe der Geschäfte von Personen,…

EQS-DD: Merck KGaA: Belén Garijo Lopez, Kauf ^ Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen,…

Merck & Co Inc (NYSE:MRK, XETRA:6MK) announced on Wednesday that it will acquire US biotech firm Terns Pharmaceuticals (NASDAQ:TERN) for…

Merck is nearing a roughly $6 billion all-cash ?deal to buy biotech firm Terns Pharma , the Financial Times reported…

Merck (MRK) reached $115.68 at the closing of the latest trading day, reflecting a +1.31% change compared to its last…